Dotmatics welcomes the Leibniz Institute
Dotmatics has welcomed the Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute – as a new customer, providing them with an academic license to the Dotmatics Platform and Vortex analytics tools to enable real-time data querying, advanced visualization, and data-driven decision-making in anti-infectives drug discovery and development.
Dotmatics is pleased to welcome the Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute – as a new customer. Their academic license of the Dotmatics Platform provides scientists with simple real-time querying and reporting on research data. Coupled with Vortex, researchers have integrated advanced analytics and data visualization capabilities to support data-driven decision-making in anti-infectives drug discovery and development.
Dr. Florian Kloss, Head of the Transfer Group Anti-infectives, comments:
Dotmatics Vortex will enable our scientists to evaluate large datasets in a rich, and flexible visualization environment and set the stage for new therapeutic approaches for infectious diseases.
Erran Twigg, VP Sales, EU at Dotmatics, adds:
We are delighted that the Hans Knöll Institute has chosen to work with Dotmatics enabling researchers to exploit all their R&D data to better inform scientific decision-making.
About The Hans Knöll Institute
The Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute – was founded in 1992 and has been a member of the Leibniz-Association since 2003. Scientists at the HKI carry out research on natural products from micro-organisms and on the infection biology of pathogenic fungi. Novel discoveries of natural products are investigated for their biological activity and modified purposefully for possible drug applications.
Related
Meet Dotmatics: Powering Life Sciences Breakthroughs with AI
The International Business Times article highlights how Dotmatics leverages AI-powered software to accelerate research, transform drug discovery, genomics, and data integration, and drive innovation for life sciences organizations across the APAC region.
Addressing Inefficient R&D Workflows
The blog discusses how legacy, fragmented R&D systems hinder innovation in complex, multi-domain scientific research by creating silos and inefficiencies, and presents Dotmatics’ unifying platform as a comprehensive solution that integrates diverse tools, data, and teams to enable smarter collaboration, governed data use, and AI-driven automation for faster, more rigorous innovation.
Dotmatics Appoints Mike McKee as President and CEO
Dotmatics Ltd has appointed experienced technology CEO Mike McKee as its new President to accelerate the company's growth, scale its global team, double R&D investments, and lead integration efforts within Insightful Science's portfolio, succeeding founder Stephen Gallagher who will focus on strategic growth initiatives.
Trends and Needs in Chemicals and Materials Innovation
Dotmatics’ VP Alister Campbell highlights that despite diverse products, Chemicals and Materials R&D teams face common challenges like regulatory pressures, tight timelines, and budgets, necessitating digitalization strategies focused on quality data management and interoperability to streamline workflows, foster collaboration, and enable AI and machine learning applications that accelerate innovation and maintain competitiveness in this evolving market.
Dotmatics Chemicals & Materials Science Software Demo
Dotmatics offers a comprehensive, end-to-end scientific software platform that digitizes and automates lab functions for chemicals and materials research, integrating best-in-class tools like GraphPad Prism and SnapGene to help over 2 million researchers overcome data challenges, improve decision-making, and accelerate R&D workflows.
About Dotmatics
Dotmatics is a science-driven company with a mission to build the world’s most powerful scientific R&D platform by uniting best-in-class software applications into a flexible, data-driven ecosystem used by over 2 million scientists worldwide, enabling collaboration, automation, and analysis to accelerate innovation and address global challenges in health, environment, and safety.